Predictive Value of Systemic Inflammatory Markers in the Prognosis of Prostate Cancer with Variant Histology.
Systemic inflammation markers have limited value in predicting prognosis among patients with variant PCA. This highlights the complex role of inflammation in cancer progression and underscores the need for further research to identify more specific biomarkers for different PCA variants.
Authors
- Muhammet Hilmi Enes Aracı
- Hüseyin Ateş (ORCID: https://orcid.org/0000-0002-2857-7923)
- Hikmet Köseoğlu (ORCID: https://orcid.org/0000-0001-5678-4981)
- Berrin Yalçın
- Emrah Okucu (ORCID: https://orcid.org/0000-0003-4465-8560)
- Semih Aktaş (ORCID: https://orcid.org/0000-0001-8180-6249)
Institutions
- University of Health Science (KH)
- Istanbul Aydın University (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- PubMed
- Published
- 2025-10-08
- DOI
- https://doi.org/10.22037/uj.v22i.8378
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00